Dr. Nelson Teng is an Advisor to GSR Ventures. He is also a managing partner at Charter Life Sciences, an early-stage healthcare fund, and chief of gynecologic oncology at Stanford University's School of Medicine. Nelson was a founder of several companies, including women's healthcare company Adeza Biomedical, biotechnology company Univax Biologics, medical device company Vesta, and biologics company SeraCare Life Sciences. Nelson has also been an advisor to Asian governments and Asia-based venture capital funds. Nelson received a PhD in biophysics from the University of California, Berkeley, an MD from the University of Miami and completed the postgraduate program at the Stanford University Graduate School of Business.